Hempfusion Wellness Inc. (CBDHF)
Hempfusion Wellness Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,635. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of -34.72 implies it has historically moved less than the broad market.
Hempfusion Wellness Inc., a health and wellness enterprise based in Vancouver, Canada, specializes in the development, promotion, and distribution of natural hemp-derived supplements and probiotic offerings throughout the United States. The company's diverse product lineup features tinctures, capsules, and topical creams under its HempFusion brand, while also providing digestive enzymes, probiotics, and skincare solutions through its Probulin brand. Additionally, it offers products under the HF Labs and Biome Research labels. These goods are accessible to consumers via its dedicated e-commerce platforms, through medical practitioners, and across a wide network of retailers, including grocery stores, pharmacies, large-scale general merchandise outlets, and convenience stores.
Hempfusion Wellness Inc. is most often compared with the following Healthcare names: